Skip to Content

Nexus AG NXU

Morningstar Rating
€52.10 −0.20 (0.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NXU is trading at a 5% discount.
Price
€51.90
Fair Value
€73.29
Uncertainty
High
1-Star Price
€59.85
5-Star Price
€74.42
Economic Moat
Ydywhk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NXU is a good fit for your portfolio.

Trading Information

Previous Close Price
€52.30
Day Range
€52.0052.40
52-Week Range
€44.3062.00
Bid/Ask
€0.00 / €0.00
Market Cap
€899.84 Mil
Volume/Avg
579 / 4,193

Key Statistics

Price/Earnings (Normalized)
33.52
Price/Sales
3.72
Dividend Yield (Trailing)
0.40%
Dividend Yield (Forward)
0.42%
Total Yield
0.56%

Company Profile

Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations specially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Growth
Total Number of Employees
1,930

Comparables

Valuation

Metric
NXU
CHG
COP
Price/Earnings (Normalized)
33.522,007.9313.98
Price/Book Value
3.534.142.21
Price/Sales
3.726.621.25
Price/Cash Flow
20.1934.617.86
Price/Earnings
NXU
CHG
COP

Financial Strength

Metric
NXU
CHG
COP
Quick Ratio
1.862.540.94
Current Ratio
1.953.001.07
Interest Coverage
16.61−2.353.95
Quick Ratio
NXU
CHG
COP

Profitability

Metric
NXU
CHG
COP
Return on Assets (Normalized)
6.32%0.11%5.59%
Return on Equity (Normalized)
9.87%0.21%15.87%
Return on Invested Capital (Normalized)
8.70%1.14%8.56%
Return on Assets
NXU
CHG
COP
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockVdqvxhx$36.3 Bil
VEEV
Veeva Systems Inc Class AZbvcjcskCnbl$32.9 Bil
SOLV
Solventum CorpCqskjdp$11.2 Bil
PMCUF
Pro Medicus LtdWsncnqy$7.8 Bil
MTHRF
M3 IncJpclkqx$7.3 Bil
MTHRY
M3 Inc ADRDjrhvc$7.3 Bil
HQY
HealthEquity IncCgymj$6.8 Bil
RCM
R1 RCM IncJkx$5.2 Bil
DOCS
Doximity Inc Class AFxgqxp$4.5 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AVlmk$3.3 Bil

Sponsor Center